A.R.T. Advisors, LLC - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$279,000
-23.4%
22,994
+0.4%
0.01%
-29.4%
Q4 2015$364,000
-1.4%
22,894
-5.0%
0.02%
+21.4%
Q3 2015$369,000
-72.7%
24,094
-56.7%
0.01%
-68.9%
Q2 2015$1,353,000
+49.7%
55,687
+43.2%
0.04%
+45.2%
Q1 2015$904,000
-5.3%
38,883
+2.2%
0.03%
-13.9%
Q4 2014$955,000
+17.8%
38,044
+9.6%
0.04%
-16.3%
Q1 2014$811,000
+25.7%
34,719
+36.6%
0.04%
+26.5%
Q4 2013$645,000
-31.3%
25,422
-44.8%
0.03%
-33.3%
Q3 2013$939,000
+115.4%
46,056
+121.4%
0.05%
+264.3%
Q2 2013$436,00020,8020.01%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders